Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akihiro Taguchi

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Chemmedchem|July 22, 2014
Discovery of natural products possessing selective eukaryotic readthrough activity: 3-epi-deoxynegamycin and its leucine adductAkihiro Taguchi, Keisuke Hamada, Masaya Kotake, et al.
Bioconjugate Chemistry|June 16, 2016
Novel Hybrid Compound of a Plinabulin Prodrug with an IgG Binding Peptide for Generating a Tumor Selective Noncovalent-Type Antibody-Drug ConjugateKyohei Muguruma, Fumika Yakushiji, Ryosuke Kawamata, et al.
Bioorganic & Medicinal Chemistry|April 6, 2020
A chemically stable peptide agonist to neuromedin U receptor type 2Kentaro Takayama, Kenji Mori, Akiko Tanaka, et al.
ACS Medicinal Chemistry Letters|July 26, 2017
Development of Potent Myostatin Inhibitory Peptides through Hydrophobic Residue-Directed Structural ModificationKentaro Takayama, Cédric Rentier, Tomo Asari, et al.
Journal of Medicinal Chemistry|May 27, 2017
Discovery of a Human Neuromedin U Receptor 1-Selective Hexapeptide Agonist with Enhanced Serum StabilityKentaro Takayama, Kenji Mori, Akiko Tanaka, et al.
European Journal of Medicinal Chemistry|September 3, 2013
Development of potent dipeptide-type SARS-CoV 3CL protease inhibitors with novel P3 scaffolds: design, synthesis, biological evaluation, and docking studiesPillaiyar Thanigaimalai, Sho Konno, Takehito Yamamoto, et al.
ACS Medicinal Chemistry Letters|June 22, 2019
Chain-Shortened Myostatin Inhibitory Peptides Improve Grip Strength in MiceKentaro Takayama, Tomo Asari, Mariko Saitoh, et al.
Chemical & Pharmaceutical Bulletin|December 17, 2025
Structure-Activity Relationship Study of Affinity Peptides for the Fc Site of Human Immunoglobulin GKyohei Muguruma, Akane Fukuda, Hayate Shida, et al.
ACS Omega|September 19, 2019
Kinetics-Based Structural Requirements of Human Immunoglobulin G Binding PeptidesKyohei Muguruma, Konomi Fujita, Akane Fukuda, et al.
European Journal of Medicinal Chemistry|June 11, 2013
Design, synthesis, and biological evaluation of novel dipeptide-type SARS-CoV 3CL protease inhibitors: structure-activity relationship studyPillaiyar Thanigaimalai, Sho Konno, Takehito Yamamoto, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Chemmedchem|July 22, 2014
Discovery of natural products possessing selective eukaryotic readthrough activity: 3-epi-deoxynegamycin and its leucine adductAkihiro Taguchi, Keisuke Hamada, Masaya Kotake, et al.
Bioconjugate Chemistry|June 16, 2016
Novel Hybrid Compound of a Plinabulin Prodrug with an IgG Binding Peptide for Generating a Tumor Selective Noncovalent-Type Antibody-Drug ConjugateKyohei Muguruma, Fumika Yakushiji, Ryosuke Kawamata, et al.
Bioorganic & Medicinal Chemistry|April 6, 2020
A chemically stable peptide agonist to neuromedin U receptor type 2Kentaro Takayama, Kenji Mori, Akiko Tanaka, et al.
ACS Medicinal Chemistry Letters|July 26, 2017
Development of Potent Myostatin Inhibitory Peptides through Hydrophobic Residue-Directed Structural ModificationKentaro Takayama, Cédric Rentier, Tomo Asari, et al.
Journal of Medicinal Chemistry|May 27, 2017
Discovery of a Human Neuromedin U Receptor 1-Selective Hexapeptide Agonist with Enhanced Serum StabilityKentaro Takayama, Kenji Mori, Akiko Tanaka, et al.
European Journal of Medicinal Chemistry|September 3, 2013
Development of potent dipeptide-type SARS-CoV 3CL protease inhibitors with novel P3 scaffolds: design, synthesis, biological evaluation, and docking studiesPillaiyar Thanigaimalai, Sho Konno, Takehito Yamamoto, et al.
ACS Medicinal Chemistry Letters|June 22, 2019
Chain-Shortened Myostatin Inhibitory Peptides Improve Grip Strength in MiceKentaro Takayama, Tomo Asari, Mariko Saitoh, et al.
Chemical & Pharmaceutical Bulletin|December 17, 2025
Structure-Activity Relationship Study of Affinity Peptides for the Fc Site of Human Immunoglobulin GKyohei Muguruma, Akane Fukuda, Hayate Shida, et al.
ACS Omega|September 19, 2019
Kinetics-Based Structural Requirements of Human Immunoglobulin G Binding PeptidesKyohei Muguruma, Konomi Fujita, Akane Fukuda, et al.
European Journal of Medicinal Chemistry|June 11, 2013
Design, synthesis, and biological evaluation of novel dipeptide-type SARS-CoV 3CL protease inhibitors: structure-activity relationship studyPillaiyar Thanigaimalai, Sho Konno, Takehito Yamamoto, et al.
Pageof 7